TriSalus Life Sciences, Inc. TLSI Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $44.88M-0.6% | $45.15M+12.3% | $40.21M+11.7% | $35.99M+12.0% | $32.14M+9.2% | ||
| $6.7M-3.8% | $6.97M+8.5% | $6.42M+16.3% | $5.52M+19.2% | $4.63M+12.8% | ||
| $38.18M0.0% | $38.19M+13.0% | $33.79M+10.9% | $30.47M+10.8% | $27.51M+8.6% | ||
| 85.1%+0.5pp | 84.6%+0.5pp | 84%-0.6pp | 84.7%-0.9pp | 85.6%-0.5pp | ||
| $14.89M+1.3% | $14.69M-2.6% | $15.08M+6.8% | $14.12M-5.0% | $14.87M-16.0% | ||
| $29.39M+2.4% | $28.71M+3.5% | $27.75M+2.6% | $27.05M+4.5% | $25.89M+0.2% | ||
| $21.94M+0.9% | $21.73M-2.2% | $22.22M+9.5% | $20.29M+9.2% | $18.59M+3.4% | ||
| -$28.03M-4.0% | -$26.95M+13.8% | -$31.26M-0.9% | -$30.98M+2.6% | -$31.82M+12.0% | ||
| -62.4%-2.8pp | -59.7%+18.1pp | -77.7%+8.3pp | -86.1%+12.9pp | -99%+23.9pp | ||
| $5.77M+4.1% | $5.54M+7.4% | $5.16M+6.6% | $4.84M+12.7% | $4.3M+39.0% | ||
| -$281K+38.4% | -$456K+6.4% | -$487K-20.0% | -$406K+1.0% | -$410K-31.4% | ||
| -$27.31M+30.4% | -$39.22M+0.9% | -$39.58M-27.0% | -$31.17M-14.6% | -$27.21M+9.4% | ||
| $6K-14.3% | $7K— | —— | —— | —— | ||
| -$27.31M+30.4% | -$39.23M+0.9% | -$39.58M-27.0% | -$31.17M-14.5% | -$27.21M+9.4% | ||
| -60.9%+26.0pp | -86.9%+11.6pp | -98.4%-11.8pp | -86.6%-1.9pp | -84.7%+17.4pp | ||
| -$1.32+24.1% | -$1.74+13.9% | -$2.02-71.2% | -$1.18-5.4% | -$1.12+15.8% | ||
| -$27.44M-4.3% | -$26.32M+13.9% | -$30.56M-1.0% | -$30.27M+2.6% | -$31.08M+12.3% | ||
| -61.1%-2.8pp | -58.3%+17.7pp | -76%+8.1pp | -84.1%+12.6pp | -96.7%+23.7pp | ||
| -$28.03M-4.0% | -$26.95M+13.8% | -$31.26M-0.9% | -$30.98M+2.6% | -$31.82M+12.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is TriSalus Life Sciences, Inc.'s revenue?
- TriSalus Life Sciences, Inc. (TLSI) generated $44.9M in revenue over the trailing twelve months, up 39.6% year over year.
- Is TriSalus Life Sciences, Inc. profitable?
- TriSalus Life Sciences, Inc. is not currently profitable: it reported a net loss of $27.3M over the trailing twelve months, a -60.9% net margin.
- What are TriSalus Life Sciences, Inc.'s profit margins?
- Gross margin is 85.1% and operating margin is -62.4%, with a -60.9% net margin.
- What is TriSalus Life Sciences, Inc.'s earnings per share?
- TriSalus Life Sciences, Inc.'s diluted EPS over the trailing twelve months is $-1.32.
- Where does TriSalus Life Sciences, Inc.'s income statement data come from?
- Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
